Michael S Wertheim Selected Research

itacitinib

1/2019

Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael S Wertheim Research Topics

Disease

3	Uveitis 06/2009 - 07/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013 - 05/2012
2	Inflammation (Inflammations) 07/2005 - 07/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Sepsis (Septicemia) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Edema (Dropsy) 11/2013
1	Posterior Uveitis 12/2008
1	Embolism (Embolus) 07/2005
1	Heart Failure 07/2005
1	Vitreous Hemorrhage 07/2005

Drug/Important Bio-Agent (IBA)

2	Infliximab (Remicade)FDA Link 06/2009 - 07/2005
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	itacitinibIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Ifosfamide FDA LinkGeneric 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	parsaclisibIBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	Janus Kinase 1IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 11/2013
1	onartuzumabIBA 11/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2013
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2013
1	XL647IBA 05/2012
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	Retinaldehyde (Retinal)IBA 12/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2005
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2005

Therapy/Procedure

3	Therapeutics 06/2009 - 07/2005
1	Drug Therapy (Chemotherapy) 01/2019